Key viral immune genes and pathways identify elite athletes with URS

Autor/innen

  • Candice Colbey School of Medical Science and Menzies Health Institute QLD, Griffith University, Southport, QLD, Australia, Griffith Uni- versity, QLD, Australia Autor/in
  • Michael K. Drew University of Canberra Research Institute of Sport and Exercise (UCRISE), Faculty of Health, University of Canberra, Can- berra, Australia Autor/in
  • Amanda J Cox School of Medical Science and Menzies Health Institute QLD, Griffith University, Southport, QLD, Australia, Griffith Uni- versity, QLD, Australia Autor/in
  • Jelena Vider School of Medical Science and Menzies Health Institute QLD, Griffith University, Southport, QLD, Australia, Griffith Uni- versity, QLD, Australia Autor/in
  • David B. Pyne University of Canberra Research Institute of Sport and Exercise (UCRISE), Faculty of Health, University of Canberra, Can- berra, Australia Autor/in
  • Nicole Vlahonich Australian Institute of Sport, Canberra, Australia Autor/in
  • David Hughes Australian Institute of Sport, Canberra, Australia Autor/in
  • Gordon Waddington University of Canberra Research Institute of Sport and Exercise (UCRISE), Faculty of Health, University of Canberra, Can- berra, Australia Autor/in
  • Renee Appaneal University of Canberra Research Institute of Sport and Exercise (UCRISE), Faculty of Health, University of Canberra, Can- berra, Australia Autor/in
  • Louise M. Burke Australian Institute of Sport, Canberra, Australia Autor/in
  • Bronwen Lundy Australian Institute of Sport, Canberra, Australia Autor/in
  • Mary Toomey Department of Physiotherapy, Griffith University, Brisbane, Australia Autor/in
  • David Watts Queensland Academy of Sport, Brisbane, Australia Autor/in
  • Gregory Lovell University of Canberra Research Institute of Sport and Exercise (UCRISE), Faculty of Health, University of Canberra, Can- berra, Australia Autor/in
  • Stephan Praet University of Canberra Research Institute of Sport and Exercise (UCRISE), Faculty of Health, University of Canberra, Can- berra, Australia Autor/in
  • Shona L. Halson School of Behavioural and Health Sciences, Australian Catholic University, Brisbane Australia Autor/in
  • Marijke Welvaert University of Canberra Research Institute of Sport and Exercise (UCRISE), Faculty of Health, University of Canberra, Can- berra, Australia Autor/in
  • Ping Zhang School of Medical Science and Menzies Health Institute QLD, Griffith University, Southport, QLD, Australia, Griffith Uni- versity, QLD, Australia Autor/in
  • Allan W. Cripps School of Medicine and Menzies Health Institute QLD, Griffith University, Southport, QLD, Australia, Griffith University, QLD, Australia Autor/in
  • Nicholas P West School of Medical Science and Menzies Health Institute QLD, Griffith University, Southport, QLD, Australia, Griffith Uni- versity, QLD, Australia Autor/in

DOI:

https://doi.org/10.22029/eir.2020.1736

Schlagwörter:

UPPER-RESPIRATORY ILLNESS, POLYMERASE-CHAIN-REACTION, BLOOD MONONUCLEAR-CELLS, EXERCISE, PERFORMANCE, EXPRESSION, INFECTION, REVEALS

Abstract

Purpose: Habitual intense exercise may increase the incidence of upper respiratory symptoms (URS) in elite athletes. This study investigated whether immune gene expression could identify gene markers that discriminate athletes with a higher prevalence of URS. Methods: This cross-sectional analysis of elite Australian athletes from various sports investigated whether athletes retrospectively reporting URS for two days or more in a month (n=38), had an altered immune gene expression profile compared with asymptomatic athletes (n=33). Peripheral blood samples were collected during Olympic selection events with corresponding URS data collected for the one-month period before sampling. Digital immune gene expression analysis was undertaken using the NanoString PanCancer Immune Profiling panel. Results: Fifty immune genes were differentially expressed between the groups (p<0.05) and approximately 78% of these genes were more highly expressed in athletes reporting URS. Many of these genes were interferon-stimulated genes or genes involved in the Jak/Stat signalling pathway. Only interferon alpha inducible protein 27 (IF127), an interferon stimulated gene involved in viral response, remained significantly higher in athletes reporting URS (log(2) fold-difference= 2.49, odds ratio 1.02 per unit increase; p<0.01) post-adjustment and discriminated athletes reporting URS from asymptomatic athletes with 78% accuracy. Conclusion: Expression of IF127 could differentiate athletes reporting URS from asymptomatic athletes, a gene that is upregulated in the immune response to viral infection. Upregulation of viral signalling pathways provides novel information on the potential aetiology of URS in elite Olympic athletes.

Literaturhinweise

Veröffentlicht

2026-07-15

Ausgabe

Rubrik

Articles